{"status":"ok","message-type":"work","message-version":"1.0.0","message":{"indexed":{"date-parts":[[2025,10,19]],"date-time":"2025-10-19T18:25:18Z","timestamp":1760898318747,"version":"3.40.5"},"reference-count":93,"publisher":"MedCrave Group Kft.","issue":"1","content-domain":{"domain":[],"crossmark-restriction":false},"short-container-title":["jnmr"],"DOI":"10.15406\/jnmr.2014.01.00004","type":"journal-article","created":{"date-parts":[[2015,2,26]],"date-time":"2015-02-26T12:24:09Z","timestamp":1424953449000},"source":"Crossref","is-referenced-by-count":16,"title":["The Use of Iron Oxide Nanoparticles for Pancreatic Cancer Therapy"],"prefix":"10.15406","volume":"1","author":[{"given":"Clare","family":"Hoskins","sequence":"first","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]}],"member":"6139","published-online":{"date-parts":[[2014,10,1]]},"reference":[{"key":"ref0","unstructured":"Chow AY (2010) Cell cycle control by oncogenes and tumor suppressors driving the transformation of normal cells into cancerous cells. Nature Education 3(9): 7."},{"key":"ref1","doi-asserted-by":"publisher","first-page":"19","DOI":"10.1007\/s12645-010-0003-3","article-title":"Folic acid-CdTe quantum dot conjugates and their applications for cancer cell targeting","author":"Suriamoorthy","year":"2010","unstructured":"Suriamoorthy P, Zhang X, Hao G, Joly AG, Singh S, et al. (2010) Folic acid-CdTe quantum dot conjugates and their applications for cancer cell targeting. Cancer Nanotechnology 1(1-6): 19-28.","journal-title":"Cancer Nanotechnology 1(1-6)"},{"key":"ref2","doi-asserted-by":"publisher","first-page":"533","DOI":"10.1016\/S1470-2045(01)00486-7","article-title":"Global cancer statistics in the year 2000","author":"Parkin","year":"2001","unstructured":"Parkin DM (2001) Global cancer statistics in the year 2000. Lancet Oncol 2(9): 533-543.","journal-title":"Lancet Oncol 2(9)"},{"key":"ref3","doi-asserted-by":"publisher","first-page":"1410","DOI":"10.1002\/bjs.4794","article-title":"Current standards of surgery for pancreatic cancer","author":"Alexakis","year":"2004","unstructured":"Alexakis N, Halloran C, Raraty M, Ghaneh P, Sutton R, et al. (2004) Current standards of surgery for pancreatic cancer. Br J Surg 91(11): 1410-1427.","journal-title":"Br J Surg 91(11)"},{"key":"ref4","doi-asserted-by":"publisher","first-page":"43","DOI":"10.3322\/canjclin.57.1.43","article-title":"Cancer statistics","author":"Jemal","year":"2007","unstructured":"Jemal A, Siegel R, Ward E, Murray T, Xu J, et al. (2007) Cancer statistics. Cancer J Clin 57(1): 43-66.","journal-title":"Cancer J Clin 57(1)"},{"key":"ref5","doi-asserted-by":"crossref","unstructured":"Lowenfels AB, Maisonneuve P (2006) Epidemiology and risk factors for pancreatic cancer. Best Pract Res Clin Gastroenterol 20(2): 197-209.","DOI":"10.1016\/j.bpg.2005.10.001"},{"key":"ref6","unstructured":"O'Sullivan A, Kocher HM (2007) Pancreatic cancer. Br Med J Clin Evid 11: 409-437."},{"key":"ref7","doi-asserted-by":"publisher","first-page":"1049","DOI":"10.1016\/S0140-6736(04)15841-8","article-title":"Pancreatic cancer","author":"Li","year":"2004","unstructured":"Li D, Xie K, Wolff R, Abbruzzese JL (2004) Pancreatic cancer. Lancet 363(9414): 1049-1057.","journal-title":"Lancet 363(9414)"},{"key":"ref8","doi-asserted-by":"crossref","unstructured":"Parkin DM, Bray FI, Devesa SS (2001) Cancer burden in the year 2000. The global picture. Eur J Cancer 37(Suppl 8): S4-S66.","DOI":"10.1016\/S0959-8049(01)00267-2"},{"key":"ref9","unstructured":"Ghaneh P, Costello E, Neoptolemos JP (2007) Biology and management of pancreatic cancer. Gut 56(8): 1134-1152."},{"key":"ref10","doi-asserted-by":"publisher","first-page":"327","DOI":"10.1007\/BF02924298","article-title":"Epidemiology of pancreas cancer (1988)","author":"Boyle","year":"1989","unstructured":"Boyle P, Hsieh CC, Maisonneuve P, La Vecchia C, Macfarlane GJ, et al. (1989) Epidemiology of pancreas cancer (1988). Int J Pancreatol 5(4): 327-346.","journal-title":"Int J Pancreatol 5(4)"},{"key":"ref11","doi-asserted-by":"publisher","first-page":"253","DOI":"10.1002\/ajim.4700070307","article-title":"Pancreas cancer is unrelated to the workplace in Los Angeles","author":"Mack","year":"1985","unstructured":"Mack TM, Peters JM, Yu MC, Hanisch R, Wright WE, et al. (1985) Pancreas cancer is unrelated to the workplace in Los Angeles. Am J Ind Med 7(3): 253-266.","journal-title":"Am J Ind Med 7(3)"},{"key":"ref12","doi-asserted-by":"publisher","first-page":"359","DOI":"10.1016\/j.jamcollsurg.2005.04.008","article-title":"Surgical resection after radiochemotherapy in patients with unresectable adenocarcinoma of the pancreas","author":"Cunha Sa","year":"2005","unstructured":"Cunha Sa A, Rault A, Laurent C, Adhoute X, Vendrely V, et al. (2005) Surgical resection after radiochemotherapy in patients with unresectable adenocarcinoma of the pancreas. J Am Coll Surg 201(3): 359-365.","journal-title":"J Am Coll Surg 201(3)"},{"key":"ref13","doi-asserted-by":"publisher","first-page":"23","DOI":"10.3322\/canjclin.52.1.23","article-title":"Cancer statistics 2002","author":"Jemal","year":"2002","unstructured":"Jemal A, Thomas A, Murray T, Thun M (2002) Cancer statistics 2002. CA Cancer J Clin 52(1): 23-47.","journal-title":"CA Cancer J Clin 52(1)"},{"key":"ref14","unstructured":"Sarkar FH, Li Y, Wang Z, Kong D (2009) Pancreatic cancer stem cells and EMT in drug resistance and metastasis. Minerva Chir 64(5): 489-500."},{"key":"ref15","doi-asserted-by":"publisher","first-page":"1840","DOI":"10.1002\/smll.200700351","article-title":"Nanoplatforms for targeted molecular imaging in living subjects","author":"Cai","year":"2007","unstructured":"Cai W, Chen X (2007) Nanoplatforms for targeted molecular imaging in living subjects. Small 3(11): 1840-1854.","journal-title":"Small 3(11)"},{"key":"ref16","doi-asserted-by":"crossref","unstructured":"Cai W, Hsu AR, Li ZB, Chen X (2007) Are quantum dots ready for in vivo imaging in human subjects? Nanoscale Res Lett 2(6): 265-281.","DOI":"10.1007\/s11671-007-9061-9"},{"key":"ref17","doi-asserted-by":"publisher","first-page":"200","DOI":"10.1016\/j.ejpb.2010.12.005","article-title":"Reversible targeting and controlled release delivery of daunorubicin cancer cells by aptamer-wrapped carbon nanotubes","author":"Taghdisi","year":"2011","unstructured":"Taghdisi SM, Lavaee P, Ramezani M, Abnous K (2011) Reversible targeting and controlled release delivery of daunorubicin cancer cells by aptamer-wrapped carbon nanotubes. Eur J Pharm Biopharm 77(2): 200-226.","journal-title":"Eur J Pharm Biopharm 77(2)"},{"key":"ref18","doi-asserted-by":"publisher","first-page":"23","DOI":"10.1007\/s10439-005-9002-7","article-title":"Super paramagnetic iron oxide nanoparticle probes for molecular imaging","author":"Thorek","year":"2006","unstructured":"Thorek DL, Chen AK, Czupryna J, Tsourkas A (2006) Super paramagnetic iron oxide nanoparticle probes for molecular imaging. Ann Biomed Eng 34(1): 23-38.","journal-title":"Ann Biomed Eng 34(1)"},{"key":"ref19","doi-asserted-by":"publisher","first-page":"1396","DOI":"10.1016\/j.bbamem.2013.01.020","article-title":"Targeting gemcitabine containing liposomes to CD44 expressing pancreatic adenocarcinoma cells causes an increase in the antitumor activity","author":"Dalla Pozza","year":"2013","unstructured":"Dalla Pozza E, Lerda C, Costanzo C, Donadelli M, Dando I, et al. (2013) Targeting gemcitabine containing liposomes to CD44 expressing pancreatic adenocarcinoma cells causes an increase in the antitumor activity. Biochim Biophys Acta 1828(5): 1396-1404.","journal-title":"Biochim Biophys Acta 1828(5)"},{"key":"ref20","doi-asserted-by":"publisher","first-page":"681","DOI":"10.2217\/17435889.2.5.681","article-title":"Gold nanoparticles: interesting optical properties and recent applications in cancer diagnostics and therapy","author":"Huang","year":"2007","unstructured":"Huang X, Jain PK, El-Sayed IH, El-Sayed MA (2007) Gold nanoparticles: interesting optical properties and recent applications in cancer diagnostics and therapy. Nanomedicine (Lond) 2(5): 681-693.","journal-title":"Nanomedicine (Lond) 2(5)"},{"key":"ref21","doi-asserted-by":"publisher","first-page":"161","DOI":"10.1038\/nrc1566","article-title":"Cancer nanotechnology: opportunities and challenges","author":"Ferrari","year":"2005","unstructured":"Ferrari M (2005) Cancer nanotechnology: opportunities and challenges. Nat Rev Cancer 5(3): 161-171.","journal-title":"Nat Rev Cancer 5(3)"},{"key":"ref22","doi-asserted-by":"publisher","first-page":"307","DOI":"10.1586\/14737159.6.3.307","article-title":"Nanotechnology for cancer diagnostics: promises and challenges","author":"Grodzinski","year":"2006","unstructured":"Grodzinski P, Silver M, Molnar LK (2006) Nanotechnology for cancer diagnostics: promises and challenges. Expert Rev Mol Diagn 6(3): 307-318.","journal-title":"Expert Rev Mol Diagn 6(3)"},{"key":"ref23","doi-asserted-by":"publisher","first-page":"2013","DOI":"10.1126\/science.281.5385.2013","article-title":"Semiconductor nanocrystals as fluorescent biological labels","author":"Bruchez Jr","year":"1998","unstructured":"Bruchez Jr M, Moronne M, Gin P, Weiss S, Alivisatos AP (1998) Semiconductor nanocrystals as fluorescent biological labels. Science 281(5385): 2013-2016.","journal-title":"Science 281(5385)"},{"key":"ref24","doi-asserted-by":"crossref","unstructured":"Chan WC, Nie S (1998) Quantum dot bio conjugates for ultrasensitive nonisotopic detection. Science 281(5385): 2016-2018.","DOI":"10.1126\/science.281.5385.2016"},{"key":"ref25","doi-asserted-by":"publisher","first-page":"1043","DOI":"10.1016\/j.nano.2012.01.005","article-title":"Quantitative molecular profiling of biomarkers for pancreatic cancer with functionalized quantum dots","author":"Lee","year":"2012","unstructured":"Lee KH, Galloway JF, Park J, Dvoracek CM, Dallas M, et al. (2012) Quantitative molecular profiling of biomarkers for pancreatic cancer with functionalized quantum dots. Nanomedicine 8(7): 1043-1051.","journal-title":"Nanomedicine 8(7)"},{"key":"ref26","doi-asserted-by":"publisher","first-page":"301","DOI":"10.1016\/S0304-8853(00)01254-3","article-title":"Optimization of ferro\ufb02uids and protocols for the enrichment of breast tumor cells in blood","author":"Liberti","year":"2001","unstructured":"Liberti PA, Rao CG, Terstappen LWMM (2001) Optimization of ferro\ufb02uids and protocols for the enrichment of breast tumor cells in blood. J Magn Mater 225(1-2): 301-307.","journal-title":"J Magn Mater 225(1-2)"},{"key":"ref27","unstructured":"Lawaczeck R, Bauer H, Frenzel T, Hasegawa M, Ito Y, et al. (1997) Magnetic iron oxide particles coated with carboxydextran for parenteral administration and liver contrasting. Acta Radiol 38(4 Pt 1): 584-597."},{"key":"ref28","unstructured":"Meyers PH, Cronic F, Nice CM Jr (1963) Experimental approach in the use and magnetic control of metallic iron particles in the lymphatic and vascular system of dogs as a contrast and isotopic agent. Am J Roentgenol Radium Ther Nucl Med 90: 1068-1977."},{"key":"ref29","doi-asserted-by":"publisher","first-page":"82","DOI":"10.1016\/j.jconrel.2014.07.059","article-title":"Comparison of active, passive and magnetic targeting to tumors of multifunctional paclitaxel\/SPIO-loaded nanoparticles for tumor imaging and therapy","volume":"194","author":"Schleich","year":"2014","unstructured":"Schleich N, Po C, Jacobs D, Ucakar B, Gallez B, et al. (2014) Comparison of active, passive and magnetic targeting to tumors of multifunctional paclitaxel\/SPIO-loaded nanoparticles for tumor imaging and therapy. J Control Release 194: 82-91.","journal-title":"J Control Release"},{"key":"ref30","doi-asserted-by":"publisher","first-page":"40","DOI":"10.1063\/1.1984765","article-title":"Magnetism in medicine","author":"Freeman","year":"1960","unstructured":"Freeman MW, Arrott A, Watson JHL (1960) Magnetism in medicine. J Appl Phys 31: S404.","journal-title":"J Appl Phys 31"},{"key":"ref31","unstructured":"Joubert JC, Quim AN (1997) Magnetic Microcomposites as Vectors for Bioactive. Agents: The State of Art. Int Ed: 93 S70."},{"key":"ref32","doi-asserted-by":"publisher","first-page":"132","DOI":"10.1016\/S0304-8853(98)00584-8","article-title":"Targeting and retention of magnetic targeted carriers (MTCs) enhancing intra-arterial chemotherapy","author":"Goodwin","year":"1999","unstructured":"Goodwin S, Peterson C, Hoh C, Bittner C (1999) Targeting and retention of magnetic targeted carriers (MTCs) enhancing intra-arterial chemotherapy. J Magn Magn Mater 194(1-3): 132-139.","journal-title":"J Magn Magn Mater 194(1-3)"},{"key":"ref33","doi-asserted-by":"publisher","first-page":"197","DOI":"10.1016\/S0304-8853(98)00552-6","article-title":"Temperature distribution as function of time around a small spherical heat source of local magnetic hyperthermia","author":"Andra","year":"1999","unstructured":"Andra W, d'Ambly CG, Hergt R, Hilger I, Kaiser WA (1999) Temperature distribution as function of time around a small spherical heat source of local magnetic hyperthermia. J Magn Magn Mater 194(1-3): 197-203.","journal-title":"J Magn Magn Mater 194(1-3)"},{"key":"ref34","doi-asserted-by":"publisher","first-page":"170","DOI":"10.1097\/00004424-200003000-00003","article-title":"Effects of magnetic thermoablation in muscle tissue using iron oxide particles: an in vitro study","author":"Hilger","year":"2000","unstructured":"Hilger I, Hergt R, Kaiser WA (2000) Effects of magnetic thermoablation in muscle tissue using iron oxide particles: an in vitro study. Invest Radiol 35(3): 170-179.","journal-title":"Invest Radiol 35(3)"},{"key":"ref35","doi-asserted-by":"publisher","first-page":"2622","DOI":"10.1016\/j.actbio.2014.01.025","article-title":"Synthesis and characterization of CREKA-conjugated iron oxide nanoparticles for hyperthermia applications","author":"Kruse","year":"2014","unstructured":"Kruse AM, Meenach SA, Anderson KW, Hilt JZ (2014) Synthesis and characterization of CREKA-conjugated iron oxide nanoparticles for hyperthermia applications. Acta Biomater 10(6): 2622-2629.","journal-title":"Acta Biomater 10(6)"},{"key":"ref36","doi-asserted-by":"publisher","first-page":"337","DOI":"10.1016\/S1535-6108(03)00276-9","article-title":"Advancing the field of drug delivery: taking aim at cancer","author":"Moses","year":"2003","unstructured":"Moses MA, Brem H, Langer R (2003) Advancing the field of drug delivery: taking aim at cancer. Cancer Cell 4(5): 337-341.","journal-title":"Cancer Cell 4(5)"},{"key":"ref37","doi-asserted-by":"crossref","unstructured":"Farokhzad OC, Langer R (2006) Developing smarter therapeutic and diagnostic modalities. Adv Drug Deliv Rev 58(14): 1456-1459.","DOI":"10.1016\/j.addr.2006.09.011"},{"key":"ref38","doi-asserted-by":"publisher","first-page":"11600","DOI":"10.1073\/pnas.0502680102","article-title":"Carbon nanotubes as multifunctional biological transporters and near infrared agents for selective cancer cell destruction","author":"Kam","year":"2005","unstructured":"Kam NW, O'Connell M, Wisdom JA, Dai H (2005) Carbon nanotubes as multifunctional biological transporters and near infrared agents for selective cancer cell destruction. Proc Natl Acad Sci USA 102(33): 11600-11605.","journal-title":"Proc Natl Acad Sci USA 102(33)"},{"key":"ref39","doi-asserted-by":"publisher","first-page":"571","DOI":"10.1039\/b410943k","article-title":"Biomedical applications of functionalized carbon nanotubes","volume":"5","author":"Bianco","year":"2005","unstructured":"Bianco A, Kostarelos K, Partidos DC, Prato M (2005) Biomedical applications of functionalized carbon nanotubes. Chem Commun (Camb) 5: 571-577.","journal-title":"Chem Commun (Camb)"},{"key":"ref40","doi-asserted-by":"publisher","first-page":"3","DOI":"10.1166\/jbn.2005.004","article-title":"Applications of carbon nanotubes in biotechnology and biomedicine","author":"Bekyarova","year":"2005","unstructured":"Bekyarova E, Ni Y, Malarkey EB, Montana V, McWilliams JL, et al. (2005) Applications of carbon nanotubes in biotechnology and biomedicine. J Biomed Nanotechnol 1(1): 3-17.","journal-title":"J Biomed Nanotechnol 1(1)"},{"key":"ref41","doi-asserted-by":"publisher","first-page":"527","DOI":"10.1039\/b314481j","article-title":"Advances toward bio applications of carbon nanotubes","author":"Lin","year":"2004","unstructured":"Lin Y, Taylor S, Li H, Shiral Fernando KA, Qu L, et al. (2004) Advances toward bio applications of carbon nanotubes. J Mater Chem 14(4): 527-541.","journal-title":"J Mater Chem 14(4)"},{"key":"ref42","doi-asserted-by":"publisher","first-page":"5527","DOI":"10.1021\/nn1025687","article-title":"Correlating physicochemical with toxicological properties of nanoparticles: the present and the future","author":"Rivera Gil","year":"2010","unstructured":"Rivera Gil P, Oberdorster G, Elder A, Puntes V, Parak WJ (2010) Correlating physicochemical with toxicological properties of nanoparticles: the present and the future. ACS Nano 4(10): 5527-5531.","journal-title":"ACS Nano 4(10)"},{"key":"ref43","doi-asserted-by":"crossref","unstructured":"Warheit DB (2008) How meaningful are the results of nanotoxicity studies in the absence of adequate material characterization? Toxicol Sci 101(2): 183-185.","DOI":"10.1093\/toxsci\/kfm279"},{"key":"ref44","doi-asserted-by":"publisher","first-page":"1310","DOI":"10.1158\/1078-0432.CCR-07-1441","article-title":"Therapeutic nanoparticles for drug deliver in cancer","author":"Cho","year":"2008","unstructured":"Cho K, Wang X, Nie S, Chen ZG, Shin DM (2008) Therapeutic nanoparticles for drug deliver in cancer. Clin Cancer Res 14(5): 1310-1316.","journal-title":"Clin Cancer Res 14(5)"},{"key":"ref45","doi-asserted-by":"publisher","first-page":"117","DOI":"10.1016\/j.jconrel.2012.03.020","article-title":"Doxil \u00ae--the first FDA approved nanodrug: lessons learned","author":"Barenholz","year":"2012","unstructured":"Barenholz Y (2012) Doxil \u00ae--the first FDA approved nanodrug: lessons learned. J Control Release 160(2): 117-134.","journal-title":"J Control Release 160(2)"},{"key":"ref46","doi-asserted-by":"publisher","first-page":"2694","DOI":"10.1007\/s11095-010-0268-6","article-title":"In vitro and in vivo anticancer activity of a novel nano-sized formulation based on self-assembling polymers against pancreatic cancer","author":"Hoskins","year":"2010","unstructured":"Hoskins C, Ouaissi M, Lima SC, Cheng WP, Loureirio I, et al. (2010) In vitro and in vivo anticancer activity of a novel nano-sized formulation based on self-assembling polymers against pancreatic cancer. Pharm Res 27(12): 2694-2703.","journal-title":"Pharm Res 27(12)"},{"key":"ref47","doi-asserted-by":"crossref","unstructured":"Brana MF, Ramos A (2001) Naphthalimides as anti-cancer agents: synthesis and biological activity. Curr Med Chem Anticancer Agents 1(3): 237-255.","DOI":"10.2174\/1568011013354624"},{"key":"ref48","doi-asserted-by":"crossref","unstructured":"Lin PK, Pavlov VA (2000) The synthesis and In vitro cytotoxic studies of novel bis-naphthalimidopropyl polyamine derivatives. Bioorg Med Chem Lett 10(14): 1609-1612.","DOI":"10.1016\/S0960-894X(00)00293-6"},{"key":"ref49","unstructured":"Netti PA, Berk DA, Swartz MA, Grodzinsky AJ, Jain RK (2000) Role of extracellular matrix assembly in interstitial transport in solid tumors. Cancer Res 60(9): 2497-2503."},{"key":"ref50","doi-asserted-by":"publisher","first-page":"353","DOI":"10.1016\/j.addr.2012.09.011","article-title":"Delivery of molcular and cellular medicine to solid tumors","author":"Jain","year":"2012","unstructured":"Jain RK (2012) Delivery of molcular and cellular medicine to solid tumors. Adv Drug Deliv Rev 64(Suppl): 353-365.","journal-title":"Adv Drug Deliv Rev 64(Suppl)"},{"key":"ref51","doi-asserted-by":"publisher","first-page":"2426","DOI":"10.1073\/pnas.1018382108","article-title":"Multistage nanoparticle delivery system for deep penetration into tumor tissue","author":"Wong","year":"2011","unstructured":"Wong C, Styliano poulos T, Cui J, Martin J, Chauhan VP, et al. (2011) Multistage nanoparticle delivery system for deep penetration into tumor tissue. Proc Natl Acad Sci USA 108(6): 2426-2431.","journal-title":"Proc Natl Acad Sci USA 108(6)"},{"key":"ref52","doi-asserted-by":"publisher","first-page":"555","DOI":"10.1016\/j.bioeng.2007.08.006","article-title":"Carbon encapsulated magnetic nanoparticles for biomedical applications: thermal stability studies","author":"Bystrejewski","year":"2007","unstructured":"Bystrejewski M, Cudzilo S, Huczko A, Lange H, Soucy G, et al. (2007) Carbon encapsulated magnetic nanoparticles for biomedical applications: thermal stability studies. Biomol Eng 24(5): 555-558.","journal-title":"Biomol Eng 24(5)"},{"key":"ref53","doi-asserted-by":"publisher","first-page":"213","DOI":"10.1016\/j.nantod.2010.05.003","article-title":"Functionalization of nanoparticles for biomedical applications","volume":"5","author":"NTK","year":"2010","unstructured":"Thanh NTK, Green L (2010) Functionalization of nanoparticles for biomedical applications. Nano Today 5: 213-230.","journal-title":"Nano Today"},{"key":"ref54","doi-asserted-by":"publisher","first-page":"362","DOI":"10.1016\/j.addr.2009.11.008","article-title":"Better safe than sorry: understanding the toxicological properties of inorganic nanoparticles manufactured for biomedical applications","author":"Fadeel","year":"2010","unstructured":"Fadeel B, Garcia-Bennett AE (2010) Better safe than sorry: understanding the toxicological properties of inorganic nanoparticles manufactured for biomedical applications. Adv Drug Deliv Rev 62(3): 362-374.","journal-title":"Adv Drug Deliv Rev 62(3)"},{"key":"ref55","doi-asserted-by":"crossref","unstructured":"Gupta AK, Gupta M (2005) Synthesis and surface engineering of iron oxide nanoparticles for biomedical applications. Biomaterials 26(18): 3995-4021.","DOI":"10.1016\/j.biomaterials.2004.10.012"},{"key":"ref56","doi-asserted-by":"publisher","first-page":"587","DOI":"10.1016\/j.ijantimicag.2008.12.004","article-title":"Characterisation of copper oxide nanoparticles for antimicrobial applications","author":"Ren","year":"2009","unstructured":"Ren G, Hu D, Cheng EW, Vargas-Reus MA, Reip P, et al. (2009) Characterisation of copper oxide nanoparticles for antimicrobial applications. Int J Antimicrob Agents 33(6): 587-590.","journal-title":"Int J Antimicrob Agents 33(6)"},{"key":"ref57","doi-asserted-by":"publisher","first-page":"2107","DOI":"10.1016\/j.fct.2011.05.025","article-title":"Designing and surface modi\ufb01cation of zinc oxide nanoparticles for biomedical applications","author":"Ansari","year":"2011","unstructured":"Ansari SA, Hussain Q, Qayyum S, Azam A (2011) Designing and surface modi\ufb01cation of zinc oxide nanoparticles for biomedical applications. Food Chem Toxicol 49(9): 2107-2115.","journal-title":"Food Chem Toxicol 49(9)"},{"key":"ref58","doi-asserted-by":"crossref","unstructured":"Ansari SA, Hussain Q (2011) Immobilization of kluyveromyces lactis b galactosidase on concanavalin A layered aluminium oxide nanoparticles\u2014its future aspects in biosensor applications. J Mol Catal B Enzymatic 70(3-4): 119-126.","DOI":"10.1016\/j.molcatb.2011.02.016"},{"key":"ref59","doi-asserted-by":"publisher","first-page":"2643","DOI":"10.1016\/j.carbon.2007.08.010","article-title":"The reliability and limits of the MTT reduction assay for carbon nanotubes-cell interaction","author":"Belyanskaya","year":"2007","unstructured":"Belyanskaya L, Manser P, Spohn P, Bruinink A, Wick P (2007) The reliability and limits of the MTT reduction assay for carbon nanotubes-cell interaction. Carbon 45(13): 2643-2648.","journal-title":"Carbon 45(13)"},{"key":"ref60","doi-asserted-by":"publisher","first-page":"697","DOI":"10.1016\/j.tiv.2009.02.007","article-title":"Mesoporous silica nanoparticles enhance MTT formazan exocytosis in HeLa cells and astrocytes","author":"Fisichella","year":"2009","unstructured":"Fisichella M, Dabboue H, Bhattacharyya S, Saboungi ML, Salvetat JP, et al. (2009) Mesoporous silica nanoparticles enhance MTT formazan exocytosis in HeLa cells and astrocytes. Toxicol In Vitro 23(4): 697-703.","journal-title":"Toxicol In Vitro 23(4)"},{"key":"ref61","doi-asserted-by":"publisher","first-page":"1417","DOI":"10.1021\/mp900083m","article-title":"Cell uptake and in vitro toxicity of magnetic nanoparticles suitable for drug delivery","author":"Hafeli","year":"2009","unstructured":"Hafeli UO, Riffle JS, Harris-Shekhawat L, Carmichael-Baranauskas A, Mark F, et al. (2009) Cell uptake and in vitro toxicity of magnetic nanoparticles suitable for drug delivery. Mol Pharm 6(5): 1417-1428.","journal-title":"Mol Pharm 6(5)"},{"key":"ref62","doi-asserted-by":"crossref","unstructured":"Acar HYC, Garaas RS, Syud F, Bonitatebus P, Kulkarni AM (2005) Super paramagnetic nanoparticles stabilized by polymerized PEGylated coatings. J Magn Magn Mater 293(1): 1-7.","DOI":"10.1016\/j.jmmm.2005.01.035"},{"key":"ref63","doi-asserted-by":"publisher","first-page":"483","DOI":"10.1016\/j.jmmm.2005.01.064","article-title":"Super paramagnetic nanoparticles for biomedical applications: possibilities and limitations of a new drug delivery system","author":"Neuberger","year":"2005","unstructured":"Neuberger T, Schopf B, Hofmann H, Hofmann M, Rechenberg BV (2005) Super paramagnetic nanoparticles for biomedical applications: possibilities and limitations of a new drug delivery system. J Magn Magn Mater 293(1): 483-496.","journal-title":"J Magn Magn Mater 293(1)"},{"key":"ref64","doi-asserted-by":"publisher","first-page":"467","DOI":"10.1016\/j.addr.2009.03.007","article-title":"Magnetic nanoparticles for theragnostics","author":"Shubayev","year":"2009","unstructured":"Shubayev VI, Pisanic TR, Jin S (2009) Magnetic nanoparticles for theragnostics. Adv Drug Deliv Rev 61(6): 467-477.","journal-title":"Adv Drug Deliv Rev 61(6)"},{"key":"ref65","doi-asserted-by":"crossref","unstructured":"Minotti G, Aust SD (1987) The requirement for Iron (III) in the initiation of lipid peroxidation by Iron (II) and hydrogen peroxide. J Biol Chem 262(3): 1098-1104.","DOI":"10.1016\/S0021-9258(19)75755-X"},{"key":"ref66","doi-asserted-by":"crossref","unstructured":"Hoskins C, Wang L, Cheng WP, Cuschieri A (2012) Dilemmas in the reliable estimation of the in-vitro cell viability in magnetic nanoparticle engineering: which tests and what protocols? Nanoscale Res Lett 7: 77.","DOI":"10.1186\/1556-276X-7-77"},{"key":"ref67","doi-asserted-by":"publisher","first-page":"15","DOI":"10.1186\/1477-3155-10-15","article-title":"Cytotoxicity of polycationic iron oxide nanoparticles: Common endpoint assays and alternative approaches for improved understanding of cellular response mechanism","volume":"10","author":"Hoskins","year":"2012","unstructured":"Hoskins C, Cuschieri A, Wang L (2012) Cytotoxicity of polycationic iron oxide nanoparticles: Common endpoint assays and alternative approaches for improved understanding of cellular response mechanism. J Nanobiotechnology 10: 15.","journal-title":"J Nanobiotechnology"},{"key":"ref68","doi-asserted-by":"crossref","unstructured":"Mak SY, Chen DH (2005) Binding and sulfonation of poly(acrylic acid) on iron oxide nanoparticles: a novel, magnetic, strong acid cation nano-adsorbent. Macromolecular Rapid Communications 26(19): 1567-1571.","DOI":"10.1002\/marc.200500397"},{"key":"ref69","doi-asserted-by":"publisher","first-page":"310","DOI":"10.1016\/j.mee.2013.02.021","article-title":"Sterilization on dextran-coatted iron oxide nanoparticles: Effects of autoclaving, filtration UV irradiation, and ethanol treatment","volume":"111","author":"Li","year":"2013","unstructured":"Li L, Mak KY, Shi J, Leung CH, Wong CM, et al. (2013) Sterilization on dextran-coatted iron oxide nanoparticles: Effects of autoclaving, filtration UV irradiation, and ethanol treatment. Microelectronic Engineering 111: 310-313.","journal-title":"Microelectronic Engineering"},{"key":"ref70","doi-asserted-by":"publisher","first-page":"365","DOI":"10.1007\/s12274-009-9035-6","article-title":"Control of aggregation size of polyethyleneimine-coated magnetic nanoparticles for magnetofection","volume":"2","author":"Wang","year":"2009","unstructured":"Wang X, Zhou L, Ma Y, Li X, Gu H (2009) Control of aggregation size of polyethyleneimine-coated magnetic nanoparticles for magnetofection. Nano Res 2: 365-372.","journal-title":"Nano Res"},{"key":"ref71","doi-asserted-by":"publisher","first-page":"2900","DOI":"10.1021\/la0008636","article-title":"Synthesis and characterization of silicacoated iron oxide nanoparticles in microemulsion: the effect of non-ionic surfactants","author":"Santra","year":"2001","unstructured":"Santra S, Tapec C, Theodoropoulou N, Dobson J, Hebard A, et al. (2001) Synthesis and characterization of silicacoated iron oxide nanoparticles in microemulsion: the effect of non-ionic surfactants. Langmuir 17(10): 2900-2906.","journal-title":"Langmuir 17(10)"},{"key":"ref72","doi-asserted-by":"publisher","first-page":"160","DOI":"10.1016\/j.bbagen.2013.08.025","article-title":"Synthesis and toxicity characterization of carbon coated iron oxide nanoparticles with highly defined size distributions","author":"Mendes","year":"2014","unstructured":"Mendes RG, Koch B, Bachmatiuk A, El-Gendy AA, Krupskaya Y, et al. (2014) Synthesis and toxicity characterization of carbon coated iron oxide nanoparticles with highly defined size distributions. Biochim Biophys Acta: General Subjects 1840(1): 160-169.","journal-title":"Biochim Biophys Acta"},{"key":"ref73","doi-asserted-by":"publisher","first-page":"187","DOI":"10.1016\/j.jcis.2005.01.013","article-title":"Magnetite nanoparticles with tunable gold or silver shell","author":"Mandal","year":"2005","unstructured":"Mandal M, Kundu S, Ghosh SK, Panigrahi S, Sau TK, et al. (2005) Magnetite nanoparticles with tunable gold or silver shell. J Colloid Interface Sci 286(1): 187-194.","journal-title":"J Colloid Interface Sci 286(1)"},{"key":"ref74","doi-asserted-by":"crossref","unstructured":"Prabhu VM, Hudson SD (2009) Nanoparticle assembly: DNA provides control. Nat Mater 8(5): 365-366.","DOI":"10.1038\/nmat2436"},{"key":"ref75","doi-asserted-by":"publisher","first-page":"2153","DOI":"10.1021\/nl900726s","article-title":"Nanoparticle superstructures made by polymerase chain reaction: collective interactions of nanoparticles and a new principle for chiral materials","author":"Chen","year":"2009","unstructured":"Chen W, Bian A, Agarwal A, Liu L, Shen H, et al. (2009) Nanoparticle superstructures made by polymerase chain reaction: collective interactions of nanoparticles and a new principle for chiral materials. Nano Lett 9(5): 2153-2159.","journal-title":"Nano Lett 9(5)"},{"key":"ref76","doi-asserted-by":"publisher","first-page":"182","DOI":"10.1088\/0022-3727\/36\/13\/202","article-title":"The preparation of magnetic nanoparticles for applications in biomedicine","author":"Tartaj","year":"2003","unstructured":"Tartaj P, Morales MD, Veintemillas-Verdaguer S, Gonzalez-Carreno T, Serna CJ (2003) The preparation of magnetic nanoparticles for applications in biomedicine. J Phys D-Appl Phys 36(13): 182-197.","journal-title":"J Phys D-Appl Phys 36(13)"},{"key":"ref77","doi-asserted-by":"publisher","first-page":"1780","DOI":"10.1029\/JB078i011p01780","article-title":"Super paramagnetic and single-domain threshold sizes in magnetite","author":"Dunlop","year":"1973","unstructured":"Dunlop DJ (1973) Super paramagnetic and single-domain threshold sizes in magnetite. J Geophys Res 78(11): 1780-1793.","journal-title":"J Geophys Res 78(11)"},{"key":"ref78","unstructured":"Bate G (1980) Recording Materials Chapter 7, in Ferromagnetic Materials. Wohlfarth, Elsevier, North Holland 2: 381-507."},{"key":"ref79","doi-asserted-by":"publisher","first-page":"1334","DOI":"10.1002\/smll.200801328","article-title":"Surface functionalization of single superparamagnetic iron oxide nanoparticles for targeted magnetic resonance imaging","author":"Amstad","year":"2009","unstructured":"Amstad E, Zurcher S, Mashaghi A, Wong JY, Textor M, et al. (2009) Surface functionalization of single superparamagnetic iron oxide nanoparticles for targeted magnetic resonance imaging. Small 5(11): 1334-1342.","journal-title":"Small 5(11)"},{"key":"ref80","doi-asserted-by":"crossref","unstructured":"Moghimi SM, Hunter AC, Murray JC (2001) Long-circulating and target-specific nanoparticles: theory to practice. Pharmacol Rev 53(2): 283-318.","DOI":"10.1016\/S0031-6997(24)01494-7"},{"key":"ref81","doi-asserted-by":"publisher","first-page":"3715","DOI":"10.1021\/cm0203013","article-title":"Nanochemistry: synthesis and characterization of multifunctional nanoclinics for biological application","volume":"14","author":"Levy","year":"2002","unstructured":"Levy L, Sahoo Y, Kim KS, Bergey EJ, Prasad PN (2002) Nanochemistry: synthesis and characterization of multifunctional nanoclinics for biological application. Chem Mater 14: 3715-3721.","journal-title":"Chem Mater"},{"key":"ref82","unstructured":"Koseoglu Y, Y\u0131ld\u0131z F, Kim DK, Muhammed M, Aktas B (2004) EPR studies on Na-oleate coated Fe3O4 nanoparticles, Second Seeheim. Conference on Magnetism 1(12): 3511-3515."},{"key":"ref83","unstructured":"Chen S (2010) Polymer coated iron oxide nanoparticle for biomedical imaging. Massachusetts Institute of Technology."},{"key":"ref84","doi-asserted-by":"publisher","first-page":"167","DOI":"10.1088\/0022-3727\/36\/13\/201","article-title":"Applications of magnetic nanoparticles in biomedicine","volume":"36","author":"Pankhurst","year":"2003","unstructured":"Pankhurst QA, Connolly J, Jones SK, Dobson J (2003) Applications of magnetic nanoparticles in biomedicine. J Phys D: Appl Phys 36: 167-181.","journal-title":"J Phys D"},{"key":"ref85","unstructured":"Gneveckow U, et al. (2005) Magnetic force nanotherapy Biomed. Tech 50: 92-93."},{"key":"ref86","doi-asserted-by":"publisher","first-page":"33","DOI":"10.1049\/ip-nbt:20055018","article-title":"Use of magnetic nanoparticle heating in the treatment of breast cancer","author":"Hilger","year":"2005","unstructured":"Hilger I, Hergt R, Kaiser WA (2005) Use of magnetic nanoparticle heating in the treatment of breast cancer. IEE Proc Nanobiotechnol 152(1): 33-39.","journal-title":"IEE Proc Nanobiotechnol 152(1)"},{"key":"ref87","doi-asserted-by":"publisher","first-page":"293","DOI":"10.1088\/0953-8984\/18\/38\/s26","article-title":"Magnetic particle hyperthermia: nanoparticle magnetism and materials development for cancer therapy","author":"Hergt","year":"2006","unstructured":"Hergt R, Dutz S, Muller R, Zeisberger M (2006) Magnetic particle hyperthermia: nanoparticle magnetism and materials development for cancer therapy. J Phys: Condens Matter 18: S2919-S2934.","journal-title":"J Phys Condens Matter 18 S2919-S"},{"key":"ref88","doi-asserted-by":"publisher","first-page":"228","DOI":"10.1002\/(SICI)1522-2586(199902)9:2<228::AID-JMRI12>3.0.CO;2-K","article-title":"Improved delineation of human brain tumors on MR images using a long-circulating, super paramagnetic iron oxide agent","author":"Enochs","year":"1999","unstructured":"Enochs WS, Harsh G, Hochberg F, Weissleder R (1999) Improved delineation of human brain tumors on MR images using a long-circulating, super paramagnetic iron oxide agent. J Magn Reson Imaging 9(2): 228-232.","journal-title":"J Magn Reson Imaging 9(2)"},{"key":"ref89","doi-asserted-by":"publisher","first-page":"456","DOI":"10.1111\/j.1365-2990.2004.00557.x","article-title":"Imaging of iron oxide nanoparticles by MR and light microscopy in patients with malignant brain tumors","author":"Neuwelt","year":"2004","unstructured":"Neuwelt EA, Varallyay P, Bago AG, Muldoon LL, Nesbit G, et al. (2004) Imaging of iron oxide nanoparticles by MR and light microscopy in patients with malignant brain tumors. Neuropathol Appl Neurobiol 30(5): 456-471.","journal-title":"Neuropathol Appl Neurobiol 30(5)"},{"key":"ref90","doi-asserted-by":"publisher","first-page":"2064","DOI":"10.1021\/cr068445e","article-title":"Magnetic iron oxide nanoparticles: Synthesis, stabilization, vectorization, physicochemical characterizations, and biological applications","author":"Laurent","year":"2008","unstructured":"Laurent S, Forge D, Port M, Roch A, Robic C, et al. (2008) Magnetic iron oxide nanoparticles: Synthesis, stabilization, vectorization, physicochemical characterizations, and biological applications. Chem Rev 108(6): 2064-2110.","journal-title":"Chem Rev 108(6)"},{"key":"ref91","doi-asserted-by":"crossref","unstructured":"Carthy JR, Weissleder R (2008) Multifunctional magnetic nanoparticles for targeted imaging and therapy. Adv Drug Deliv Rev 60(11): 1241-1251.","DOI":"10.1016\/j.addr.2008.03.014"},{"key":"ref92","doi-asserted-by":"crossref","unstructured":"Vu-Quang H, Muthiah M, Lee HJ, Kim YK, Rhee JH, et al. (2012) Immune cell-specific delivery of beta-glucan-coated inron oxide nanoparticle","DOI":"10.1016\/j.carbpol.2011.08.091"}],"container-title":["Journal of Nanomedicine Research"],"original-title":[],"link":[{"URL":"http:\/\/medcraveonline.com\/JNMR\/JNMR-01-00004.php","content-type":"unspecified","content-version":"vor","intended-application":"similarity-checking"}],"deposited":{"date-parts":[[2025,5,20]],"date-time":"2025-05-20T02:39:40Z","timestamp":1747708780000},"score":1,"resource":{"primary":{"URL":"https:\/\/medcraveonline.com\/JNMR\/the-use-of-iron-oxide-nanoparticles-for-pancreatic-cancer-therapy.html"}},"subtitle":[],"short-title":[],"issued":{"date-parts":[[2014,10,1]]},"references-count":93,"journal-issue":{"issue":"1","published-online":{"date-parts":[[2014,10,1]]}},"URL":"https:\/\/doi.org\/10.15406\/jnmr.2014.01.00004","relation":{},"ISSN":["2377-4282"],"issn-type":[{"type":"electronic","value":"2377-4282"}],"subject":[],"published":{"date-parts":[[2014,10,1]]}}}